Epidemiology of Pulmonary Embolism in Apulia from analysis of current data

Moretti, Anna; Tafuri, Silvio; Parisi, Davide; Germinario, Cinzia

doi:10.4081/monaldi.2010.309

Cited by 9 publications

(8 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The two independent reviewers were in agreement on the classified level of evidence for 8671 (99%) of the 8702 reviewed citations; the remaining 31 citations were classified after discussion and consensus between the reviewers. The final classification designated 29 citations as level A evidence , 29 as level B evidence , and the remainder as other. Most of the level A studies evaluated the incidence of VTE or its components, DVT and/or PE ; two studies evaluated the prevalence of VTE .…”

Section: Resultsmentioning

confidence: 99%

“…This evidence comes from only two of the seven global super‐regions designated by GBD 2010: those designated ‘High Income’, and ‘Southeast Asia, East Asia, and Oceania’. Within the high‐income super‐region, 11 level A studies were from western Europe , 10 were from North America, two were from Australasia (both from Australia) , one was from the southern Latin America region (Argentina) , and one was from the Asia Pacific region (Korea) . The three level A studies from the super‐region of ‘Southeast Asia, East Asia, and Oceania’ all came from the region of East Asia (two studies from Hong Kong and one from Taiwan).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Thrombosis: a major contributor to the global disease burden

Raskob

Angchaisuksiri

Blanco

et al. 2014

Journal of Thrombosis and Haemostasis

377

126

View full text Add to dashboard Cite

Summary Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2010 documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden caused by VTE in low‐income, middle‐income and high‐income countries. Studies from western Europe, North America, Australia and southern Latin America (Argentina) yielded consistent results, with annual incidence rates ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥ 70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low, because of population aging. VTE associated with hospitalization was the leading cause of disability‐adjusted life‐years (DALYs) lost in low‐income and middle‐income countries, and the second most common cause in high‐income countries, being responsible for more DALYs lost than nosocomial pneumonia, catheter‐related bloodstream infections, and adverse drug events. VTE causes a major burden of disease across low‐income, middle‐income and high‐income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate whether improved utilization of preventive measures will reduce the burden.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Thrombosis: a major contributor to the global disease burden

Raskob

Angchaisuksiri

Blanco

et al. 2014

Journal of Thrombosis and Haemostasis

377

126

View full text Add to dashboard Cite

show abstract

“…Within the High Income super region, 11 level A studies were from the region of Western Europe [8,[14][15][16][17][18][19][20][21][22][23], 10 were from North America, 2 were from Australasia (both from Australia) [33,34], one was from the Southern Latin America region (Argentina) [35], and one was from the Asia Pacific region (Korea) [36]. The three level A studies from the super region of "Southeast Asia, East Asia, and Oceania" all came from the region of East Asia [37][38][39] (two studies from Hong Kong and one from Taiwan).…”

Section: Incidence Of Vtementioning

confidence: 99%

Thrombosis: A major contributor to global disease burden

Raskob¹,

Angchaisuksiri²,

Blanco³

et al. 2014

Thrombosis Research

445

399

View full text Add to dashboard Cite

Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low, middle and high income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted-life-years (DALYs) lost in low and middle income countries, and second in high income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low, middle, and high income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilization of preventive measures will reduce the burden.

show abstract

“…The population of patients with VTE is smaller in Asian populations compared with Western populations (DVT, 5.3–30 vs. 78–269; PE, 3.9–11.7 vs. 45–189, per 100,000 population, Asian vs. Western populations). 2) 5) 6) 7) 8) 9) 10) 11) 12) 13) 14) 15) 16) …”

Section: Introductionmentioning

confidence: 99%

Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009–2016: a Nationwide Study Based on the National Health Insurance Service Database

Kim

Chang

Kim

et al. 2021

J Cardiovasc Imaging

View full text Add to dashboard Cite

BACKGROUND The annual incidence of venous thromboembolism (VTE) is increasing, and the treatment pattern of oral anticoagulants (OACs) has changed with introduction of new oral anticoagulants (NOACs). The aims of this study were to assess the annual incidence of VTE in a Korean population and the change of treatment pattern with availability of NOACs using a population-based database. METHODS Using the Korean National Health Insurance Services database, we identified patients diagnosed with VTE between 2009 and 2016. The annual prevalence of VTE and clinical characteristics and treatment pattern were investigated. The annual incidence of VTE was calculated using direct and indirect methods using the estimated Korean population in 2009 as the reference. RESULTS The annual incidence of VTE in Korean has increased yearly from 23.9 per 100,000 in 2009 to 42.2 in 2016. The overall rate of OAC prescription for VTE treatment increased from 55.9% to 68% in the same time period. The rate of initiation of NOAC treatment greatly increased, particularly from 2013 onwards, with a 20-fold increase from 2009 to 2016 (2.1% vs. 54.3%). CONCLUSIONS The annual incidence of VTE in Korea increased by almost two-fold from 2009 to 2016. The rate of initiation of NOAC treatment has increased substantially since 2013, and these agents have surpassed VKAs as the anticoagulant of choice for VTE. This temporal pattern of OAC prescription is consistent with the current clinical guidelines, which indicate NOACs over the warfarin in patients with VTE.

show abstract

Epidemiology of Pulmonary Embolism in Apulia from analysis of current data

Cited by 9 publications

References 21 publications

Thrombosis: a major contributor to the global disease burden

Thrombosis: a major contributor to the global disease burden

Thrombosis: A major contributor to global disease burden

Epidemiology of Venous Thromboembolism and Treatment Pattern of Oral Anticoagulation in Korea, 2009–2016: a Nationwide Study Based on the National Health Insurance Service Database

Contact Info

Product

Resources

About